Yazar "Nalbantgil, S." seçeneğine göre listele
Listeleniyor 1 - 20 / 91
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Apical hypertrophic cardiomyopathy can mimic ischemic, heart diseases(Elsevier Science Bv, 2007) Duygu, H.; Zoghi, M.; Nalbantgil, S.; Ozerkan, F.; Akilli, A.; Akin, M.Öğe Assessment of Right Ventricular Systolic Function in Heart Transplant Patients: Correlation between Echocardiography and Cardiac Magnetic Resonance Imaging. Investigation of the Accuracy and Reliability of Echocardiography(Elsevier Science Inc, 2013) Simsek, E.; Nalbantgil, S.; Ceylan, N.; Zoghi, M.; Engin, C.; Yagdi, T.; Ozbaran, M.Öğe The Association Between the Low Percentage of Forced Vital Capacity and Increased Mortality After LVAD Operation(Amer Thoracic Soc, 2018) Ekren, P. Korkmaz; Ertugay, S.; Ozturk, P.; Ozdil, A.; Nalbantgil, S.; Engin, C.; Yagdi, T.; Ozbaran, M.Öğe Burden and the clinical significance of the retained cardiac implantable electronic device components after heart transplantation(Oxford Univ Press, 2019) Simsek, E.; Tamnik, F.; Demir, E.; Nalbantgil, S.[No abstract available]Öğe CHA2DS2-Vasc and HAS-BLED Scores as Predictors of Ischemic and Hemorrhagic Stroke Risk After Left Ventricular Assist Device Implantation(Elsevier Science Inc, 2015) Kemal, H. S.; Ertugay, S.; Nalbantgil, S.; Zoghi, M.; Engin, C.; Yagdi, T.; Ozbaran, M.Öğe CHA2DS2-Vasc and HAS-BLED Scores as Predictors of Ischemic and Hemorrhagic Stroke Risk After Left Ventricular Assist Device Implantation(Elsevier Science Inc, 2015) Kemal, H. S.; Ertugay, S.; Nalbantgil, S.; Zoghi, M.; Engin, C.; Yagdi, T.; Ozbaran, M.Öğe CHA2DS2-Vasc and HAS-BLED Scores as Predictors of Ischemic and Hemorrhagic Stroke Risk After Left Ventricular Assist Device Implantation(Elsevier Science Inc, 2015) Kemal, H. S.; Ertugay, S.; Nalbantgil, S.; Zoghi, M.; Engin, C.; Yagdi, T.; Ozbaran, M.Öğe Changes in plasma neprilysin levels after left ventricular assist device implantation and association of outcomes during 1-year follow-up(Wiley, 2019) Yuce, E. I. Elif Ilkay; Demir, E.; Simsek, E.; Ozturk, P.; Parildar, Z.; Engin, C.; Yagdi, T.; Ozbaran, M.; Nalbantgil, S.; Gurgun, C.Öğe Changes in plasma neprilysin levels after left ventricular assist device implantation and association with short-term outcomes(Oxford Univ Press, 2018) Yuce, E. I.; Demir, E.; Simsek, E.; Ozturk, P.; Parildar, Z.; Engin, C.; Yagdi, T.; Ozbaran, M.; Nalbantgil, S.; Gurgun, C.Öğe A circadian rhythm of syncope in patients with vasovagal syncope(Oxford Univ Press, 2006) Zoghi, M.; Duygu, H.; Nalbantgil, S.; Yavuzgil, O.; Akin, M.; Payzin, S.; Akilli, A.Öğe Clinical and prognostic significance of heart rate variability in pulmonary arterial hypertension(Oxford Univ Press, 2014) Kayikcioglu, M.; Musayev, O.; Nalbantgil, S.; Mogulkoc, N.; Vuran, O.; Musayev, K.; Kultursay, H.Öğe Clinical and Prognostic Significance of Heart Rate Variability in Pulmonary Hypertension(Elsevier Science Inc, 2014) Musayev, O.; Kayikcioglu, M.; Nalbantgil, S.; Mogulkoc, N.; Vuran, O.; Musayev, K.; Kultursay, H.Öğe Clinical Characteristics of Obstructive Sleep Apnea Syndrome in Heart Transplant Recipients(Elsevier Science Inc, 2013) Ayik, S.; Gungor, H.; Ayik, M. F.; Engin, C.; Yagdi, T.; Nalbantgil, S.; Akhan, G.; Ozberan, M.Aim. We investigated the prevalence and clinical characteristics of obstructive sleep apnea syndrome (OSAS) among heart transplantation patients. Methods. Among 86 surviving patients of mean age 43.07 +/- 13.23 years including 35 men transplanted from April 1999 to November 2010, 43 (50%) agreed to participate in this study. Patients with apnea-hypopnea index (AHI) < 5 were labeled as "normal", with an AHI > 5, as obstructive surgeon (OSA). According to the ART, subjects were classified as with OSA (group 1; n = 25 of mean age 49.0 +/- 12.1 years and including 21 men versus non OSA group 2; n = 18) of mean age 34.8 +/- 10.1 years with 14 men. We recorded patient demographic features, medications, polysomnographi observations, laboratory measurements, as well as echocardiographic and angiographic parameters. Results. Prevalence of OSA (AHI > 5) was 58% (n = 25) with 30% (n = 14) as moderate or severe OSA (AHI > 15) OSA patients were significantly older, and showed a greater value of body mass index (BMI) and waist circumference. Echocardiographic findings revealed the only significant difference to be systolic arterial pressure. The apnea-hypopnea index showed significant correlation with age, BMI, waist circumference, neck circumference, Epworth score, duration of apnea episode, time of SaO(2) under 90% and systolic arterial pressure (SPAP). An inverse correlation was observed between ART and sleep efficiency, oxygen saturation, and percentage of time in random eye movement (REM) sleep. Multivariate backward logistic regression analysis indicated waist circumference, sleep efficiency, percentage of time in REM sleeps and duration of apnea episode to be independent predictors of AHI. Conclusion. OSA is prevalent among heart transplantation patients. Obesity is a risk factor and waist circumference, and independent predictor for OSA.Öğe Clinical Characteristics of Obstructive Sleep Apnea Syndrome in Heart Transplant Recipients(Elsevier Science Inc, 2013) Ayik, S.; Gungor, H.; Ayik, M. F.; Engin, C.; Yagdi, T.; Nalbantgil, S.; Akhan, G.; Ozberan, M.Aim. We investigated the prevalence and clinical characteristics of obstructive sleep apnea syndrome (OSAS) among heart transplantation patients. Methods. Among 86 surviving patients of mean age 43.07 +/- 13.23 years including 35 men transplanted from April 1999 to November 2010, 43 (50%) agreed to participate in this study. Patients with apnea-hypopnea index (AHI) < 5 were labeled as "normal", with an AHI > 5, as obstructive surgeon (OSA). According to the ART, subjects were classified as with OSA (group 1; n = 25 of mean age 49.0 +/- 12.1 years and including 21 men versus non OSA group 2; n = 18) of mean age 34.8 +/- 10.1 years with 14 men. We recorded patient demographic features, medications, polysomnographi observations, laboratory measurements, as well as echocardiographic and angiographic parameters. Results. Prevalence of OSA (AHI > 5) was 58% (n = 25) with 30% (n = 14) as moderate or severe OSA (AHI > 15) OSA patients were significantly older, and showed a greater value of body mass index (BMI) and waist circumference. Echocardiographic findings revealed the only significant difference to be systolic arterial pressure. The apnea-hypopnea index showed significant correlation with age, BMI, waist circumference, neck circumference, Epworth score, duration of apnea episode, time of SaO(2) under 90% and systolic arterial pressure (SPAP). An inverse correlation was observed between ART and sleep efficiency, oxygen saturation, and percentage of time in random eye movement (REM) sleep. Multivariate backward logistic regression analysis indicated waist circumference, sleep efficiency, percentage of time in REM sleeps and duration of apnea episode to be independent predictors of AHI. Conclusion. OSA is prevalent among heart transplantation patients. Obesity is a risk factor and waist circumference, and independent predictor for OSA.Öğe Clinical, echocardiographic and haemodynamic predictors of morbidity and mortality in pulmonary hypertension: a nation-wide registry(Oxford University Press, 2024) Akbulut, M.; Kaymaz, C.; Basarici, I; Yildirimturk, O.; Asker, M.; Yaylali, T.; Tokgozoglu, L.; Nalbantgil, S.[Abstract Not Available]Öğe Comparison of cardiac output measurement methods for mortality prediction in pulmonary hypertension(Oxford Univ Press, 2018) Simsek, E.; Bayazit, Y.; Demir, E.; Kayikcioglu, M.; Nalbantgil, S.; Mogolkoc, N.; Can, L.; Kultursay, H.Öğe Comparison of Heart Transplantation Patients with Ischemic and Idiopathic Dilated Cardiomyopathy(Elsevier Science Inc, 2011) Gungor, H.; Oguz, E.; Ayik, M. F.; Ertugay, S.; Engin, C.; Yagdi, T.; Nalbantgil, S.; Zoghi, M.; Ozbaran, M.Objective. We retrospectively analyzed our data to compare preoperative demographic, laboratory, echocardiographic, hemodynamic findings mortality and survival rates of heart transplantation patients with ischemic (ICM) and idiopathic dilated (IDCM) cardiomyopathy. Methods. The data of 144 patients transplanted from February 1998 to January 2011 were analyzed. 38 patients with ischemic ICM and 86 patients with IDCM were compared. Results. Recipient age, preoperative creatinine, recipient body mass index, intraoperative cross-clamp time, donor male sex ratio, recipient male sex ratio, hyperlipidemia ratio, and previous nitrate use were significantly higher and left ventricular end systolic diameter significantly lower in patients with ICM. Major causes of death after heart transplantation were infections (31.9%), right ventricle failure (14.8%), and sudden cardiac death (14.8%). Causes of death were not different between the groups. Overall mortality in the entire population was 37.9% (47/124), and it was not different between the groups (39.5% vs 37.2%; P =.48). Early mortality (<30 days) rate was 11.2% (14/124), late mortality rate was 26.6% (33/124), and no statistically significant difference was observed between the groups. Survival analysis showed that ICM patients were not associated with worse survival compared with IDCM (71.1% vs 81.1% after 1 year, 68.1% vs 73.0% at 2 years, and 54.2% vs 62.3% at 5 years; log rank = 0.57). Multivariate analysis showed that the only predictor of mortality was preoperative urea level and that heart failure etiology was not a predictor of this end point. Conclusions. Patients with ICM had similar survival and mortality rate compared with IDCM.Öğe COST-EFFECTIVENESS OF RIOCIGUAT FOR TREATMENT OF PATIENTS WITH INOPERABLE OR POST-OPERATIVE RECURRENT/PERSISTENT CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) IN TURKEY(Elsevier Science Inc, 2015) Erdal, E.; Ozdemir, O.; Yildizeli, B.; Kaymaz, C.; Okumus, G.; Mogulkoc, N.; Nalbantgil, S.; Deger, C.; Sumer, F.; Parali, E.; Tunalioglu, A.; Sar, C.; Asan, S.; Ozel, O.Öğe COST-EFFECTIVENESS OF RIOCIGUAT FOR TREATMENT OF PATIENTS WITH INOPERABLE OR POST-OPERATIVE RECURRENT/PERSISTENT CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) IN TURKEY(Elsevier Science Inc, 2015) Erdal, E.; Ozdemir, O.; Yildizeli, B.; Kaymaz, C.; Okumus, G.; Mogulkoc, N.; Nalbantgil, S.; Deger, C.; Sumer, F.; Parali, E.; Tunalioglu, A.; Sar, C.; Asan, S.; Ozel, O.Öğe COST-EFFECTIVENESS OF RIOCIGUAT FOR TREATMENT OF PATIENTS WITH INOPERABLE OR POST-OPERATIVE RECURRENT/PERSISTENT CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) IN TURKEY(Elsevier Science Inc, 2015) Erdal, E.; Ozdemir, O.; Yildizeli, B.; Kaymaz, C.; Okumus, G.; Mogulkoc, N.; Nalbantgil, S.; Deger, C.; Sumer, F.; Parali, E.; Tunalioglu, A.; Sar, C.; Asan, S.; Ozel, O.
